Drug Profile
Levacecarnine
Alternative Names: Acetyl-L-carnitine; ALC; Alcar; Branigen; L-acetylcarnitine; Nicetile; RO 447190; ST 200; ST 211HCl; ZibrenLatest Information Update: 16 Aug 2023
Price :
$50
*
At a glance
- Originator sigma-tau SpA
- Developer Dong-A ST; GlaxoSmithKline; sigma-tau SpA; Tanabe Seiyaku
- Class Antidementias; Neuroprotectants; Quaternary ammonium compounds; Small molecules
- Mechanism of Action Carnitine acetyltransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Alzheimer's disease; Dementia; Diabetic neuropathies; Peripheral nervous system diseases
- Discontinued Diabetic complications; Fatigue